Research on the usefulness of pneumococcal polysaccharide vaccine for elderly in the nursing home

Research on the usefulness of pneumococcal polysaccharide vaccine for elderly in the nursing home - Pneumococcal vaccine study for elderly in the nursing home

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002189

Enrollment

2000

Registered

2009-07-17

Start date

2008-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia in the nursing home

Interventions

23-valent pneumococcal polysaccharide vaccine Sterile saline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Influenza vaccination before enrollment 2. No previous immunization with 23-valent pneumococcal polysaccharide vaccine 3. elderly utilizing the nursing home 4. With written informed consent

Exclusion criteria

Exclusion criteria: 1. person who have malignancy 2. person under dialysis 3. person who are taking food non-orally 4. person who had infectious diseases including pneumonia during last one month

Design outcomes

Primary

Measure	Time frame
Incidence of pneumonia and admission due to pneumonia	—

Secondary

Measure	Time frame
Medical cost due to pneumonia	—

Countries

Japan

Contacts

Public ContactKazunori Oishi

Research Institute for Microbial Diseases, Osaka University International Center for Infectious Diseases

oishik@biken.osaka-u.ac.jp06-6879-4253

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026